• Quotes
  • Shortcuts
The Executive's Internet
Tues, May 24th



Setup News Ticker
Searching for 'Wall stocks'. (Return)

Washington Post BusinessMay 24, 2022
Stocks poised for a downturn as Wall Street's wild ride continues
Wall Street pointed to another sell-off as S&P 500 remains close to bear territory.

CNBC FinanceMay 23, 2022
S&P 500 rises more than 1%, Dow adds 600 points as stocks try to recover from sharp sell-off
Stocks jumped Monday as the market tried to recover some of the losses from a relentless sell-off that has gripped Wall Street.

MarketWatch MarketPulseMay 23, 2022
Dow climbs more than 600 points, U.S. stocks end sharply higher as Wall Street banks jump
All three major stock benchmarks ended sharply higher Monday, kicking off the week with gains as shares in the financials sector jumped. The Dow Jones Industrial Average closed up almost 619 points, or about 2%, while the S&P 500 climbed around 1.9% and the Nasdaq Composite rose about 1.6%, according to preliminary FactSet data. The financials sector booked the biggest gains in the S&P 500 index, rising around 3.2% Monday, as Wall Street banks JPMorgan Chase & Co. and Citigroup Inc. each jumped around 6%, preliminary FactSet data show.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

KiplingerMay 03, 2022
Bausch Lomb IPO: What You Need to Know
Bausch Lomb, a well-known leader in eye care, is about to hit Wall Street in what investment bankers almost certainly hope will jump-start a weak initial public offering (IPO) market.

Bausch Health Companies (BHC) is a global healthcare stock that develops pharmaceuticals, medical devices and over-the-counter medications, with focus areas in eye health, gastroenterology and dermatology.

SEE MORE 7 Best Biotech Stocks to Build Your Portfolio However, to help streamline its operations and pay down debt, Bausch is spinning off its Bausch Lomb eye care division in what is shaping up to be one of 2022's most anticipated IPOs.

Bausch Lomb sells contact lenses, eye drops and even implantable lenses for cataract surgery in more than 100 countries. The division boasts more than 400 products, more than 260 of which came on the market since 2017.

You can thank Bausch Lomb's robust R&D arm, which has about 850 employees. The current product pipeline includes more than 100 projects, such as treatments for dry eye, contact lenses to slow myopia, and next-gen cataract equipment.

The focus on innovation has helped to grow the top line. For 2021, division revenues jumped by 10.6% to $3.8 billion - part of BHC's overall revenues of $8.4 billion, up 5% - and the company flipped from a loss of $17 million to a net gain of $193 million.

"While it faces significant competition from other brands and generic products, the company is highly profitable with strong cash flow

stockmarket Buy Earnings Snap Dow
stocksBuy market Dow these Snap
BusinessChina How Insider Futures Airbnb
BuyStocks Stock Best Earnings These
ChinaBiden Airbnb Taiwan business defend
SalesBuy Best Earnings Stock decline
SnapWarning Stock Tech 30% Dow
EarningsStock Buy beat Nvidia Ahead
Dowstock down Stocks points futures
BidenTaiwan China Asia trip CNN

Top News (Business News)
Accounting Today
AdWeek News
Banking Business Review
Barron's This Week Magazine
Barron's Up and Down Wall Street Daily
Brad Ideas
Chicago Tribune Business News
CNBC Business
CNBC Economy
CNBC Finance
CNN/Money Real Estate News
Dismal.com: Analysis
Dismal.com: Indicators
Enterprise Application News
Forbes Headlines
Forbes Social Media News
FT.com - China, Economy & Trade
FT.com - Financial Markets
FT.com - Hedge Funds
FT.com - Telecoms
FT.com - US
Google Business News
Google Market News
HBS Working Knowledge
INSEAD Knowledge
International Tax Review
L.S. Starrett News
MarketWatch Breaking News
MarketWatch MarketPulse
McKinsey Quarterly
MSNBC.com: Business
Nielsen Trends
NonProfit Times
NPR Topics: Business
NYTimes Business
Private Equity Breaking News
Reuters Business
Reuters Company News
Reuters Money
SEC.gov Updates: News Digest
Tax Policy News
The Economist International News
The Motley Fool
USA Today Money
Wall Street Journal US Business
Wall Street Transcript
Washington Post Business
WSJ Asia
WSJ Europe
WSJ MoneyBeat
WSJ Opinion
WSJ World Markets
Yahoo Business
  • CEOExpress
  • 1 Boston Place | Suite 2600
    Boston MA 02108
  • Contact
  • As an Amazon Associate
    CEOExpress earns from
    qualifying purchases.

©1999-2022 CEOExpress Company LLC